Search research articles
Contact Us
Filters
Showing results (11-20 of 186) with videos related to
Page
of 19
Sort By:
SAGE Open Medical Case Reports
|
September 1, 2023
Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature
Cynthia Fournier, Ian Hirsch, Anna Spreafico, et al.
Journal of the National Cancer Institute
|
February 2, 2026
Driving progress in recurrent and metastatic head and neck cancer: the NRG oncology perspective
Mercedes Herrera, Matthew Ward, Glenn J Hanna, et al.
Cancer Discovery
|
April 3, 2021
The Future of Clinical Trial Design in Oncology
Anna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, et al.
Otolaryngologic Clinics of North America
|
October 29, 2025
Treating Head and Neck Cancer in the Older Adult
Somiah Siddiq, Satya V R Garikipati, Tania Kalsi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 29, 2025
Erratum: Updates on Treatments and Management of Nasopharyngeal Carcinoma
Melvin L K Chua, Xin Zhang, Kenneth C W Wong, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 10, 2025
Updates on Treatments and Management of Nasopharyngeal Carcinoma
Melvin L K Chua, Xin Zhang, Kenneth C W Wong, et al.
Cancer Treatment Reviews
|
November 23, 2020
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Daniel V Araujo, Geoffrey A Watson, Marc Oliva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2007
Endothelial growth factor receptor inhibition after radiotherapy
Monica Giovannini, Vanesa Gregorc, Maria Grazia Viganò, et al.
Current Oncology (Toronto, Ont.)
|
January 24, 2025
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
Anna Spreafico, Eric Winquist, Cheryl Ho, et al.
Cancer Chemotherapy and Pharmacology
|
April 21, 2017
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
Sandrine Aspeslagh, Kunwar Shailubhai, Rastilav Bahleda, et al.
Page
of 19
Search research articles
Search
Showing results (11-20 of 186) with videos related to
Sort By:
Page
of 19
SAGE Open Medical Case Reports
|
September 1, 2023
Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature
Cynthia Fournier, Ian Hirsch, Anna Spreafico, et al.
Journal of the National Cancer Institute
|
February 2, 2026
Driving progress in recurrent and metastatic head and neck cancer: the NRG oncology perspective
Mercedes Herrera, Matthew Ward, Glenn J Hanna, et al.
Cancer Discovery
|
April 3, 2021
The Future of Clinical Trial Design in Oncology
Anna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, et al.
Otolaryngologic Clinics of North America
|
October 29, 2025
Treating Head and Neck Cancer in the Older Adult
Somiah Siddiq, Satya V R Garikipati, Tania Kalsi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 29, 2025
Erratum: Updates on Treatments and Management of Nasopharyngeal Carcinoma
Melvin L K Chua, Xin Zhang, Kenneth C W Wong, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 10, 2025
Updates on Treatments and Management of Nasopharyngeal Carcinoma
Melvin L K Chua, Xin Zhang, Kenneth C W Wong, et al.
Cancer Treatment Reviews
|
November 23, 2020
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Daniel V Araujo, Geoffrey A Watson, Marc Oliva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2007
Endothelial growth factor receptor inhibition after radiotherapy
Monica Giovannini, Vanesa Gregorc, Maria Grazia Viganò, et al.
Current Oncology (Toronto, Ont.)
|
January 24, 2025
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
Anna Spreafico, Eric Winquist, Cheryl Ho, et al.
Cancer Chemotherapy and Pharmacology
|
April 21, 2017
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
Sandrine Aspeslagh, Kunwar Shailubhai, Rastilav Bahleda, et al.
Page
of 19